Evidence map›Paper›PMID 41776068›Full record

Trial reportBiological trace element research2026

Association Between Trace Mineral Concentrations and Oxidative Stress in Children with ADHD Supplemented with Multinutrients.

Lisa M Robinette, Irene E Hatsu, Chieh-Ming Wu, Olorunfemi Adetona, Alisha M Bruton, Hayleigh K Ast, James B Odei, Brenda M Y Leung, Jeanette M Johnstone, Ouliana Ziouzenkova

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Biological trace element research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03252522 (Evaluating the Efficacy of Supplementation With Micronutrients for ADHD in Youth), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03252522 phase1 / phase2completednot on this map

Evaluating the Efficacy of Supplementation With Micronutrients for ADHD in Youth (MADDY) Study

TypeinterventionalSponsorOregon Health and Science UniversityRan2018 to 2021Enrolled135ConditionsAttention Deficit Hyperactivity DisorderArmsBroad Spectrum Micronutrients, a 36-ingredient blend of vitamins, minerals, amino acids, and antioxidants, Placebo
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lisa M RobinetteDepartment of Human Sciences, The Ohio State University, 29 W. Woodruff Ave, 160 Ramseyer Hall, OH, 43210, Columbus, USA.ORCID http://orcid.org/0000-0002-9314-9538
Irene E HatsuDepartment of Human Sciences, The Ohio State University, 29 W. Woodruff Ave, 160 Ramseyer Hall, OH, 43210, Columbus, USA. hatsu.1@osu.edu.ORCID http://orcid.org/0000-0003-0501-9088
Chieh-Ming WuDivision of Environmental Health Sciences, College of Public Health, The Ohio State University, Columbus, OH, USA.ORCID http://orcid.org/0000-0003-3346-6395
Olorunfemi AdetonaDivision of Environmental Health Sciences, College of Public Health, The Ohio State University, Columbus, OH, USA.ORCID http://orcid.org/0000-0001-9850-4028
Alisha M BrutonCenter for Mental Health Innovation, Psychiatry Department, Oregon Health & Science University, Portland, OR, USA.ORCID http://orcid.org/0000-0002-5929-3149
Hayleigh K AstCenter for Mental Health Innovation, Psychiatry Department, Oregon Health & Science University, Portland, OR, USA.ORCID http://orcid.org/0000-0002-2521-0309
James B OdeiDivision of Biostatistics, College of Public Health, The Ohio State University, Columbus, OH, USA.ORCID http://orcid.org/0000-0002-4018-5535
Brenda M Y LeungFaculty of Health Sciences, University of Lethbridge, Lethbridge, Canada, Alberta.ORCID http://orcid.org/0000-0002-4699-8086
Jeanette M JohnstoneCenter for Mental Health Innovation, Psychiatry Department, Oregon Health & Science University, Portland, OR, USA.ORCID http://orcid.org/0000-0003-3947-5540
Ouliana ZiouzenkovaDepartment of Human Sciences, The Ohio State University, 29 W. Woodruff Ave, 160 Ramseyer Hall, OH, 43210, Columbus, USA.ORCID http://orcid.org/0000-0003-2449-2591

Funding

Oregon Clinical and Translational Research Institute - The National COVID Cohort Collaborative (N3C)UL1TR002369 · NCATS · OREGON HEALTH & SCIENCE UNIVERSITY · PI Cynthia D Morris, Christopher G. Slatore · 2017 to 2026
$78.4M
The OSU Center for Clinical and Translational Science: Advancing Today's Discoveries to Improve HealthUL1TR002733 · NCATS · OHIO STATE UNIVERSITY · PI RINGEL, MATTHEW D · 2018 to 2022
$28.9M
CAM Research Training in Neuroscience &StressT32AT002688 · NCCIH · OREGON HEALTH & SCIENCE UNIVERSITY · PI OKEN, BARRY S, SOUMYANATH, AMALA · 2005 to 2025
$7.2M
Calgary Foundation Nutrition and Mental Health FundNational Institutes of Health (NIH) National Center for Complementary and Integrative Health K23 90281846NCATS NIH HHS UL1TR002369NCATS NIH HHS UL1TR002733NCCIH NIH HHS T32 AT002688
6 · The paper itself

Abstract

Oxidative stress (OS) arises from an imbalance between antioxidant defenses and the generation of reactive oxygen species (ROS), both of which are influenced by the levels and composition of trace elements. The Micronutrients for ADHD in Youth randomized controlled trial demonstrated behavioral improvements following 8 weeks of multinutrient supplementation in 54% of children compared to 18% on placebo. This secondary analysis examined the relationship between plasma minerals and OS-related parameters [biological antioxidant potential (BAP), glutathione peroxidase (GPx), glutathione reductase (GR), and reactive oxygen metabolites (ROM)] in 71 children (44 multinutrient, 27 placebo; median age 10.4 years). Correlation analysis revealed that selenium and zinc improved antioxidant response measured as GPx change in both treatment groups (r = 0.26, p = 0.03) and BAP in multinutrient group (r = 0.37, p = 0.01), respectively, while chromium change was inversely related to BAP (r=-0.41, p = 0.005) in the multinutrient group. BAP change was moderated by baseline selenium (β=-9.45, p = 0.006), zinc (β=-2.13, p < 0.001), and chromium (β = 68.9, p = 0.02), where children in the multinutrient group with low selenium, low zinc, and high chromium at baseline experienced BAP increases. Selenium also exhibited pro-oxidant effects: ROM change correlated positively with change in selenium in multinutrient group only (r = 0.34, p = 0.03). Baseline copper predicted ROM change (β = 0.213, p < 0.001), and ROM change correlated positively with changes in copper in both groups (r = 0.51, p < 0.001) and negatively with Mn (r=-0.24, p = 0.05), while iron did not moderate OS. Multinutrient supplementation may enhance antioxidant defenses in children who had low plasma zinc and selenium, while potential pro-oxidant effects in those with higher selenium and chromium warrant further investigation. Clinical Trial Registry number for MADDY RCT: NCT03252522.

Indexed as

Attention Deficit Disorder with HyperactivityDietary SupplementsOxidative StressTrace ElementsAntioxidantsChildFemaleGlutathione PeroxidaseHumansMaleMineralsReactive Oxygen SpeciesSeleniumZincAntioxidantsGlutathione PeroxidaseMineralsReactive Oxygen SpeciesSeleniumTrace ElementsZincADHDAntioxidantMineralMultinutrient supplementOxidative stressReactive oxygen species

Identifiers

PMID41776068
PMCPMC13320042

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.